ARTICLE | Clinical News
Compugen preclinical data
February 8, 2010 8:00 AM UTC
In a mouse model of MS, CGEN-15001 ameliorated disease symptoms, including tail and limb paralysis. In vitro, CGEN-15001 inhibited proliferation, differentiation and cytokine production of pro-inflamm...